Post-COVID worsening of a Parkinson's disease patient
- PMID: 34257979
- PMCID: PMC8259921
- DOI: 10.1002/ccr3.4409
Post-COVID worsening of a Parkinson's disease patient
Abstract
Worsening of clinical symptoms after COVID-19 infection and misregulation of CD4 and CD8 T-cell numbers may be revealed in PD patients. Immunological changes may be a source of clinical worsening of the patient.
Keywords: Parkinson's disease; Post‐COVID‐19; immunology; motor symptoms; nonmotor symptoms.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Pinto LH, Lamb RA. Understanding the mechanism of action of the anti‐influenza virus drug amantadine. Trends Microbiol. 1995;3:271. - PubMed
-
- Nie S, Zhao X, Zhao K, Zhang Z, Zhang Z, Zhang Z. Metabolic disturbances and inflammatory dysfunction predict severity of coronavirus disease 2019 (COVID‐19): a retrospective study. medRxiv. 2020. 10.1101/2020.03.24.20042283 - DOI
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
